| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 03/07/2007 | EP1758853A1 Glucagon receptor antagonists, preparation and therapeutic uses |
| 03/07/2007 | EP1758847A1 Inhibitors of histone deacetylase |
| 03/07/2007 | EP1758582A1 Amido compounds and their use as pharmaceuticals |
| 03/07/2007 | CN1926148A Beta-aminoacid-derivatives as factor Xa inhibitors |
| 03/07/2007 | CN1926122A Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
| 03/07/2007 | CN1923797A Pharmaceutical compounds |
| 03/07/2007 | CN1303074C Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 03/06/2007 | US7186829 Aryl-substituted heterocyclic enaminones |
| 03/06/2007 | US7186825 Polyamines for treatment of diseases such as cancer or treatment of tumors |
| 03/06/2007 | US7186753 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents |
| 03/06/2007 | US7186735 Vasodilation; cardiovascular disorders; anticoagulants |
| 03/06/2007 | US7186732 For therapy and prophylaxis of upper airway allergic response, nasal congestion, or allergic rhinitis, dementia, mild cognitive impairment (pre-dementia), cognitive dysfunction, schizophrenia, depression, manic disorders |
| 03/06/2007 | US7186726 Preferentially substituted calcium channel blockers |
| 03/06/2007 | US7186725 Anti-inflammatory compositions and methods |
| 03/06/2007 | US7186724 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders |
| 03/06/2007 | US7186719 Antibacterial agents |
| 03/06/2007 | US7186277 hair dyes with improved colorfastness, washfastness, photostability, color uniformity and tinctorial strength |
| 03/01/2007 | WO2007023141A1 N-oxides as prodrugs of piperazine & piperidine derivatives |
| 03/01/2007 | WO2006081273A8 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroayryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity |
| 03/01/2007 | WO2005117882A9 Hydroxamic acid derivatives as metalloprotease inhibitors |
| 03/01/2007 | US20070049594 Novel compounds and compositions as cathepsin inhibitors |
| 03/01/2007 | US20070044254 Novel 2,6-disubstituted primary para-phenylenediamines and process for their use in the oxidation dyeing of keratin fibers |
| 03/01/2007 | CA2621158A1 N-oxides as prodrugs of piperazine & piperidine derivatives |
| 02/28/2007 | EP1757670A2 Organic electroluminescent element |
| 02/28/2007 | EP1757579A1 Primary 2,6-disubstituted para-phenylenediamines and their uses for dyeing keratin fibres |
| 02/28/2007 | EP1756119A1 Collection of traceable compounds and uses thereof |
| 02/28/2007 | EP1756107A2 Aryl-substituted piperazine derivatives |
| 02/28/2007 | EP1756101A2 Androgen receptor modulators and method of treating disease using the same |
| 02/28/2007 | EP1756078A1 Phenylsulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase inhibitors |
| 02/28/2007 | EP1756063A1 Amido compounds and their use as pharmaceuticals |
| 02/28/2007 | EP1756058A1 Histamine-3 receptor antagonists |
| 02/28/2007 | EP1756044A1 Therapeutic compounds |
| 02/28/2007 | EP1756037A2 Amino alcohol derivatives and their activity as renin inhibitors |
| 02/28/2007 | EP1756036A1 Indene derivatives and process for the preparation thereof |
| 02/28/2007 | EP1755605A2 Use of (4-alkylpiperazinyl)(phenyl) methanones in the treatment of alzheimer's disease |
| 02/28/2007 | EP1755593A1 Naphthaline derivatives useful as histamine-3-receptor ligands |
| 02/28/2007 | EP1755572A2 N- (2-benzyl) -2-phenylbutanamides as androgen receptor modulators |
| 02/28/2007 | EP1755396A1 Piperazin derivatives and their use in controlling pests |
| 02/28/2007 | EP1377536A4 Self-reducing anthraquinone compounds |
| 02/28/2007 | EP1240154B1 Serine protease inhibitors |
| 02/28/2007 | EP1233013B1 Novel phenylalanine derivatives |
| 02/28/2007 | EP1025077B1 Novel aryloxy-alkyl-dialkylamines |
| 02/28/2007 | CN1922165A 3-(4-benzyloxyphenyl)propanoic acid derivative |
| 02/28/2007 | CN1922162A Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as FAAH enzyme inhibitors |
| 02/28/2007 | CN1922161A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same in therapeutics |
| 02/28/2007 | CN1921885A Method of regulating phosphorylation of sr protein and antiviral agents comprising sr protein activity regulator as the active ingredient |
| 02/28/2007 | CN1302339C Photo sensitive resin composition |
| 02/28/2007 | CN1302002C Hydroxylamine esters as polymerization initiators |
| 02/28/2007 | CN1301974C Muller Klaus-helmut |
| 02/28/2007 | CN1301964C Inhibitors of alpha 4 mediated cell adhesion |
| 02/27/2007 | US7183445 4-(4-Hydroxy-phenyl)-[4-(2-morpholin-4-yl-ethoxy)-benzyl]-methyl-cyclohex-3-enecarboxylic acid ethyl ester; estrogen receptor modulators for hot flashes, vaginal dryness, osteopenia, osteoporosis, hyperlipidemia, loss of cognitive function, degenerative brain diseases |
| 02/27/2007 | US7183438 Catalysts and method for the production of amines |
| 02/27/2007 | US7183408 calcium atorvastatin (Lipitor) intermediate; from claimed intermediate 5-(4-fluorophenyl)-2-isopropyl-1-(3-morpholin-4-yl-3-oxo-propyl)-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide; via diol esters from the 1,3,5-tricarbonyl precursors in a stereoselective ruthenium-catalyzed hydrogenation |
| 02/27/2007 | US7183323 Sodium channel modulators |
| 02/27/2007 | US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/27/2007 | US7183279 Synergistic combinations with morphine; analgesics and cyclooxygenase-2 inhibitors, such as N-5-guanidinopentanamide-(2S)-yl-2-N-(p-hydroxyphenylacetyl)phenylenediamine and N-5-guanidinopentanamide-(2R)-yl-2-N-(p-hydroxybenzyl)-5-carboxybenzimidazole |
| 02/27/2007 | US7183260 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/22/2007 | WO2006002185A8 Chemical compounds |
| 02/22/2007 | US20070043217 Method for the distillative separation of mixtures containing ethyleneamines |
| 02/22/2007 | US20070043213 Photo-initiated carbonylation with carbon-isotope labeled carbon monoxide using amines and alkyl/aryl iodides; carbon-isotope labeled amides are useful as radiopharmaceuticals, especially for use in Positron Emission Tomography |
| 02/22/2007 | US20070043079 Heterocyclic compound containing nitrogen atom and use thereof |
| 02/22/2007 | US20070042936 glycerol cyclic pyruvate derivates; inhibit the binding of an immobilized D-proline derivative to serum amyloid P componen; amyloidosis; Alzheimers disease; maturity onset diabetes mellitus |
| 02/22/2007 | US20070042271 such as N-methyl-N-methoxymethylpyrrolidinium chloride; high solubility in organic solvents, high voltage resistance and high electrical conductivity |
| 02/22/2007 | US20070039520 Method for producing bituminous compositions |
| 02/22/2007 | DE69530936C5 Boronsäure-und-esterverbindungen, deren systhese und verwendungen Boronic acid and ester compounds whose systhese and uses |
| 02/21/2007 | EP1754709A1 Process for preparing vinylphosphates |
| 02/21/2007 | EP1754477A2 Hydroxamic acid derivatives as antibacterials |
| 02/21/2007 | EP1753711A1 Method for producing quaternary ammonium compounds |
| 02/21/2007 | EP1753421A2 Arylsulfonamides and uses as hydroxysteroid dehydrogenase |
| 02/21/2007 | EP1551797B1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 02/21/2007 | EP1539676A4 Monomer compound comprising several cationic groups, process for making the same, and polymers comprising units deriving therefrom |
| 02/21/2007 | EP1361851B1 Primary intermediates for oxidative coloration of hair |
| 02/21/2007 | EP1311482B1 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/21/2007 | CN1918139A Cinnamic amides, process for their preparation, and pharmaceutical compositions containing them |
| 02/21/2007 | CN1918114A Substituted n-aryl amidines as selective d1 dopamine receptor antagonists for the treatment of obesity and cns disorders |
| 02/21/2007 | CN1915982A Method for synthesizing Ranolazine |
| 02/21/2007 | CN1915964A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/21/2007 | CN1915497A Catalyst for synthesizing morphine through diethylene glycol ammoniation, and preparation method |
| 02/20/2007 | US7179941 N-{3-[3-(2-Chloro-4,5-difluorobenzoyl)ureido]-4-methoxyphenyl}acetamide; treating type 2 diabetes |
| 02/20/2007 | US7179922 Chemical compounds |
| 02/20/2007 | US7179918 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 02/20/2007 | US7179912 Materials and methods to potentiate cancer treatment |
| 02/20/2007 | US7179911 coupling a silyl ester of (3S)-2,2-dimethyl-tetrahydro-2H-1,4-thiazine-3-carboxylic acid with 6,4-[4-(chlorosulfonyl)phenoxy]-2-butynyl acetate, hydrolyzing the silyl ester |
| 02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 02/20/2007 | US7179819 Benzyl -urea, -thiourea, or -guanidine derivatives that inhibit the binding of ligands to alpha 4 beta 1 integrin (VLA-4); for therapy and prophylaxis of pathologies associated with VLA-4 mediated cell adhesion, such as inflammatory and autoimmune diseases, and tumor metastasis |
| 02/20/2007 | US7179817 For therapy and prophylaxis of peripheral arterial disease such as arteriosclerosis obliterans, thromboangiitis obliterans, Buerger's disease or diabetic neuropathy, sepsis, angiitis, nephritis, pneumonia, stroke, myocardial infarction, edematous state, atherosclerosis, varicosity such as hemorrhoid |
| 02/20/2007 | US7179808 Such as 3-[[4-(4-chlorophenyl)-2-thiazolyl]methoxy]-N-propyl-benzenemethanamine; nicotinamide adenine dinucleotide oxidase hydride donor inhibitors |
| 02/15/2007 | WO2007018460A1 Therapeutic agents |
| 02/15/2007 | WO2007018459A1 Therapeutic agents |
| 02/15/2007 | WO2007017507A1 Beta-secretase inhibitors for use in the treatment of alzheimer's disease |
| 02/15/2007 | WO2007017267A2 Novel compounds |
| 02/15/2007 | WO2006133242A3 Azinone and diazinone v3 inhibitors for depression and stress disorders |
| 02/15/2007 | US20070037823 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 02/15/2007 | US20070037821 Nitrosated glutamic acid compounds, compositions and methods of use |
| 02/15/2007 | US20070037795 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders |
| 02/15/2007 | US20070037793 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders |
| 02/15/2007 | DE102005038376A1 Verfahren zur destillativen Abtrennung von Piperazin aus einem Ethylendiamin-Piperazin-Gemisch Process for the separation by distillation of piperazine from a mixture of ethylenediamine-piperazine |
| 02/15/2007 | CA2618013A1 Beta-secretase inhibitors for use in the treatment of alzheimer's disease |
| 02/14/2007 | EP1752454A1 Method for separating piperazine from a mixture of ethylenediamine-piperazine through destillation |
| 02/14/2007 | EP1751108A1 Adamantyl-acetamide derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |